Results 111 to 120 of about 207,642 (302)

Drug-drug interaction of paroxetine on olanzapine and initial dosage optimization in patients with major depressive disorder based on population pharmacokinetics

Frontiers in Psychiatry
ObjectiveOlanzapine is already used to treat patients with major depressive disorder; however, whether complex drug–drug interaction (DDI) has an effect on the pharmacokinetics of people using olanzapine and its initial dosage remains unknown.
Cun Zhang, Liang Chen, Yin-Yin Duan, Su-Mei He, Ya-Li Tian, Ying Gao, Dong-Dong Wang   +6 more
doaj   +1 more source

Genetic Evidence Supporting a Role for Brain Region Volume and Functional Network Alterations in Major Depression

Advanced Science, EarlyView.
Genome‐wide analyses indicate that reduced ventral diencephalon and thalamus volumes, along with decreased functional connectivity within the triple network (DMN/CEN/SN), are uniquely associated with the risk of major depression (MD) onset, compared to other similar severe psychiatric disorders.
Ming‐Min Xu, Nan Li, Yi‐Wen Lv, Wen‐Miao Yang, Zhi‐Yun Yu, Yi‐Min Zhang, Yu Guo, Xiao‐Yin Chen   +7 more
wiley   +1 more source

PMH4: THE BUDGET IMPACT PHARMACOTHERAPY SELECTION FOR MAJOR DEPRESSIVE DISORDER: A MULTINATIONAL STUDY

, 1999
JP Casciano, TR Einarson, S Arikian, JJ Doyle   +3 more
openalex   +1 more source

Early childhood risk factors differentiated juvenile onset from adult onset major depressive disorder [PDF]

, 2002
Elizabeth B. Weller
openalex   +1 more source

Oxcarbazepine for the treatment of bipolar and depressive disorders in the outpatient setting: A retrospective chart review

Psychiatry Research Communications
Oxcarbazepine is often utilized off-label for bipolar and depressive disorders in outpatient settings despite limited evidence. We performed a retrospective chart review on 38 adult outpatients diagnosed with bipolar and depressive disorders (ICD-10 ...
Brandon Brown, Brian Tong, Luke Pro, Suzanna Kitten   +3 more
doaj   +1 more source

MGPT: A Multi‐task Graph Prompt Learning Framework for Drug Discovery

Advanced Science, EarlyView.
MGPT is a unified multi‐task graph prompt learning model providing generalizable and robust graph representations for few‐shot drug association prediction. MGPT demonstrates the ability of seamless task switching and outperforms competitive approaches in few‐shot scenarios.
Yang Li, Youhan Sun, Xinyu Qin, Xin Gao, Guohua Wang   +4 more
wiley   +1 more source

PCN7: ECONOMIC ASPECTS OF AN INTERNATIONAL STUDY OF MAJOR DEPRESSIVE DISORDER IN PRIMARY CARE PATIENTS (THE LIDO STUDY)

, 1999
Daniel Chisholm, M Knapp, G. B. Simon, Michael Treglia   +3 more
openalex   +1 more source

Effects of daily events on mood states in major depressive disorder. [PDF]

, 2003
Frenk Peeters, Nancy A. Nicolson, Johannes Berkhof, Philippe Delespaul, Marten W. deVries   +4 more
openalex   +1 more source

MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) [PDF]

Malaysian Family Physician, 2011
DEVELOPMENT GROUP MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MOH MALAYSIA
doaj  

Structure‐Function Relationships of Biomass‐Derived Materials for Zinc Metal Protection

Advanced Science, EarlyView.
This review analyses the mechanism of zinc anode degradation, focuses on the protective roles of the four major functional groups of carboxyl, amino, hydroxyl, and sulfonic acid groups in biomass materials, reveals the structure‐function relationship and synergistic effects of functional groups, and looks forward to the challenges and directions of ...
Qiwei Gao, Zhuo Chen, Ya He, Zhangxiang Hao, Junrun Feng   +4 more
wiley   +1 more source